Christopher G. White

Insider Reports History

Entity
Individual
Location
C/O Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham, MA
Signature
/s/ Donald Notman, Attorney-in-Fact for Christopher G. White
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher G. White:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OCULAR THERAPEUTIX, INC Chief Business Officer Common Stock 124K $601K $4.86 Feb 5, 2024 Direct
OCULAR THERAPEUTIX, INC Chief Business Officer Stock Option (Right to Buy) 120K Feb 3, 2024 Direct

Insider Reports Filed by Christopher G. White

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OCUL OCULAR THERAPEUTIX, INC Feb 3, 2024 3 $28.7K 4 Feb 6, 2024 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Jan 31, 2024 1 -$25.5K 4 Feb 2, 2024 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Feb 6, 2023 1 -$24.7K 4 Feb 8, 2023 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Jan 30, 2023 2 $0 4 Feb 1, 2023 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Oct 13, 2022 1 $0 4 Oct 14, 2022 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Feb 3, 2022 2 $0 4 Feb 7, 2022 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Oct 1, 2021 1 $0 4 Oct 8, 2021 Chief Business Officer
OCUL OCULAR THERAPEUTIX, INC Oct 1, 2021 0 $0 3 Oct 8, 2021 Chief Business Officer